Results 61 to 70 of about 2,548 (196)
Aspergillus tubingensis: A Rare Fungal Pathogen Complicating COVID‐19 Case
Case Reports in Infectious Diseases, Volume 2025, Issue 1, 2025.Background Coronavirus disease 2019 (COVID‐19) has been associated with invasive fungal infection. Several COVID‐19 cases were complicated due to coinfection with Aspergillus, Rhizopus, and Mucor species. We present COVID‐19 with Aspergillus tubingensis coinfection.
Aiah M. Khateb +7 more
wiley +1 more source
Clinical Case Reports, Volume 12, Issue 12, December 2024.ABSTRACT Patients with end‐stage renal disease (ESRD) undergoing chronic hemodialysis are at an increased risk of developing spondylodiscitis, an infectious condition affecting the vertebral column. In this case report, we present a 22‐year‐old male with ESRD, a history of hyperoxaluria, nephrolithiasis, and anemia, who developed spondylodiscitis ...
Parisa Mehrasa +3 more
wiley +1 more source
Kidney transplantation in primary oxalosis
, 1976 A 33 yr old patient with primary oxalosis was submitted to cadaver kidney transplantation after 15 mth treatment by hemodialysis. During the dialysis period, he developed complete heart block which immediately followed bilateral nephrectomy.
Toussaint, Charles +2 more
core
Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure [PDF]
, 1995 Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure. Oxalate retention occurs in end-stage renal failure. Regular dialysis treatment does not prevent progressive accumulation of oxalate in cases of ESRF due ...
Cadario, Anna +7 more
core +1 more source
, 2002 A case of neonatal renal oxalosis in a 7-day-old calf is described. Clinical biochemistry revealed increased blood urea nitrogen. Gross findings included thin renal medulla and dilated renal calyces containing numerous, small, pale yellow and granular ...
Kaya, A, Golen, I, Gulbahar, MY
core +1 more source
British Journal of Clinical Pharmacology, Volume 90, Issue 12, Page 3176-3189, December 2024.Abstract Aim To characterize pharmacokinetic and pharmacodynamic profiles of nedosiran in patients with primary hyperoxaluria type 1 (PH1), identify influential covariates and confirm therapeutic doses. Methods A population pharmacokinetic (PK)/pharmacodynamic (PD) (POP‐PKPD) model was developed to characterize the concentration‐time course of ...
Steven Zhang +6 more
wiley +1 more source
Accelerated Oxalosis Contributing to Delayed Graft Function after Renal Transplantation
Case Reports in Transplantation, 2019 Hyperoxaluria is an important and underrecognized cause for allograft dysfunction and loss after transplantation. It is potentially treatable if recognized in a timely fashion.
Yvelynne P. Kelly +2 more
doaj +1 more source
Clinical Transplantation, Volume 38, Issue 12, December 2024.ABSTRACT Background Alemtuzumab can be an alternative to rabbit anti‐thymocyte globulin (rATG) to treat severe or glucocorticoid‐resistant acute T cell‐mediated kidney transplant rejection (TCMR). Yet, there are few reports in which these two treatments are evaluated let alone, compared.
Lukas K. van Vugt +9 more
wiley +1 more source
Oxalosis with oral manifestations in a patient with chronic renal failure
, 2017 Oxalosis resulting from hyperoxaluria caused by chronic renal failure can be speculated in rare cases among patients with multiple alveolar bone resorption and tooth root resorption events in the oral cavity ...
강상훈, 김문기
core +1 more source
Primary oxalosis with pan-conduction cardiac disease: electrophysiologic and anatomic correlation.
, 1981 A 27-year-old man with primary oxalosis and extensive visceral involvement was maintained on long-term chronic hemodialysis. He had an episode of presyncope associated with electrocardiographic findings of an erratic atrial rhythm, atrioventricular ...
B M Massie +6 more
core +1 more source